Biotech Jason Mast Even with gene therapy on the horizon, drugmakers join hunt for new sickle cell drugs
Biotech Adam Feuerstein New data in sickle cell show biotech companies tackling disease in novel ways
Biotech Adam Feuerstein Global Blood’s sickle cell disease drug heads to the FDA, but questions about patient benefit still linger
Biotech Adam Feuerstein Novel gene therapy ‘switch’ for sickle cell disease shows encouraging results in pilot trial
Adam's Take Adam Feuerstein Global Blood’s FDA filing plan for a sickle cell drug is riskier than you think
Biotech Adam Feuerstein Global Blood’s sickle cell drug works, but can FDA be persuaded to review it faster?
In the Lab Sharon Begley Gene therapy for sickle cell moves closer as scientists clear unexpected obstacle